Expert Consensus on Multidisciplinary Care for Cardiac Amyloidosis: 2023 ACC Report | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Scientific Articles

Expert Consensus on Multidisciplinary Care for Cardiac Amyloidosis: 2023 ACC Report

key information

source: Journal of the American College of Cardiology

year: 2023

authors: Michelle M. Kittleson, Frederick L. Ruberg, Amrut V. Ambardekar, Thomas H. Brannagan, Richard K. Cheng, John O. Clarke, Laura M. Dember, Janell Grazzini Frantz, Ray E. Hershberger, Mathew S. Maurer, Jose Nativi-Nicolau, Vaishali Sanchorawala, Farooq H. Sheikh

summary/abstract:

The American College of Cardiology (ACC) has a long history of developing documents (eg, decision pathways, health policy statements, appropriate use criteria) to provide members with guidance on both clinical and nonclinical topics relevant to cardiovascular care. In most circumstances, these documents have been created to complement clinical practice guidelines and to inform clinicians about areas where evidence may be new and evolving or where sufficient data may be more limited. Despite this, numerous care gaps continue to exist, highlighting the need for more streamlined and efficient processes to implement best practices in service to improved patient care.

The systemic amyloidoses are a broad spectrum of diseases that result from misfolding of proteins that aggregate into β-sheet amyloid fibrils. Over 35 amyloidogenic precursor proteins have been identified that give rise to diseases characterized by extracellular deposition of insoluble amyloid fibrils throughout various tissues and organs. In cardiac amyloidosis, amyloid fibrils accumulate in the interstitial space between cardiac myocytes, precipitating cellular injury and impairing compliance. Advanced cardiac amyloidosis is physiologically characterized as a restrictive cardiomyopathy (CM).

The nomenclature for systemic amyloidosis includes an “A” for amyloid followed by an abbreviation of the protein that misfolds. The vast majority of encountered cases of amyloid CM will be caused by misfolding of 1 of 2 proteins: 1) monoclonal immunoglobulin light chain produced in bone-marrow plasma cell disorders; and 2) transthyretin (abbreviated TTR), also known as prealbumin, a thyroxine and retinol (vitamin A) transport protein produced by the liver (the organ principally responsible for generating circulating TTR), choroid plexus, and retinal pigmented epithelium.

organization: Cedars-Sinai, USA; Boston University, USA; University of Colorado, USA; Columbia University, USA; University of Washington, USA; Stanford University, USA; University of Pennsylvania Perelman School of Medicine, USA; Mayo Clinic Rochester, USA; Ohio State University College of Medicine/Wexner Medical Center, USA; Columbia University Irving Medical Center, USA; Mayo Clinic Florida, USA; Boston Medical Center, USA; MedStar Health/Georgetown University, USA

DOI: 10.1016/j.jacc.2022.11.022

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close